CSL LIMITED

0.28%

$241.60

Market Cap $116.9B

Healthcare Biotechnology

CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus... CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The Company operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others. More

MEMPHASYS LIMITED

Many are concerned about global falling birthrates. This diverse stock has solutions. Here, then, one can’t afford to miss perusing what ASX-listed fertility tech healthcare smallcap Memphasys Ltd (ASX:MEM) can offer the world.

Latest Threads

Tag

Subject

CSL

Why is CSL tanking

2 3

14/07/25

125

57K

14/07/25

Last post bagus

125

57K

CSL

News Articles

11/07/25

3.9K

11/07/25

Last post PZ99

3.9K

CSL

$200 soon

11/07/25

27K

11/07/25

Last post R-7

27K

CSL

Ann: Notification of cessation of securities - CSL

07/07/25

384

07/07/25

Last post

ASX News

384

CSL

Ann: CSL's Andembry FDA Approved

17/06/25

1.9K

17/06/25

Last post W534220

1.9K

CSL

Ann: Appointment of New Director

11/06/25

931

11/06/25

Last post bagus

931

CSL

Ann: Notification of cessation of securities - CSL

04/06/25

464

04/06/25

Last post

ASX News

464

CSL

Share buybacks

22/05/25

990

22/05/25

Last post W534220

990

See All Discussions

Timeline

Notification of cessation of securities - CSL
07 Jul 11:51	Share

CSL's Andembry FDA Approved
17 Jun 08:37	Share

Appointment of New Director
10 Jun 09:23	Share

Notification of cessation of securities - CSL
04 Jun 13:01	Share

Notification of cessation of securities - CSL
21 May 11:25	Share

Notification of cessation of securities - CSL
08 May 10:26	Share

Shareholder Information Meetings
05 May 08:26	Share

Notification of cessation of securities - CSL
10 Apr 10:01	Share

CSL Responds to Proposed USA Tariffs
03 Apr 11:22	Share

Change of Director's Interest Notice
17 Mar 12:21	Share

Notification of cessation of securities - CSL
13 Mar 10:33	Share

Update - Dividend/Distribution - CSL
13 Mar 09:01	Share

Notification regarding unquoted securities - CSL
11 Mar 15:18	Share

Application for quotation of securities - CSL
11 Mar 15:13	Share

Notification regarding unquoted securities - CSL
05 Mar 12:34	Share

Notification regarding unquoted securities - CSL
19 Feb 16:00	Share

Notification regarding unquoted securities - CSL
19 Feb 15:56	Share

Change of Director's Interest Notice
19 Feb 15:50	Share

Dividend/Distribution - CSL
11 Feb 08:11	Share

CSL Half Year Results Investor Presentation
11 Feb 08:11	Share

CSL Half Year Results Announcement
11 Feb 08:11	Share

CSL Statutory Accounts for the Half Year Ended 31 Dec 2024
11 Feb 08:10	Share

Notice of Investor/Analyst Briefing 2025 Half Year Result
07 Feb 16:23	Share

Notification of cessation of securities - CSL
07 Feb 11:07	Share

Notification of cessation of securities - CSL
14 Jan 09:56	Share

Change in substantial holding
19 Dec 08:11	Share

Notification of cessation of securities - CSL
09 Dec 14:09	Share

Notification regarding unquoted securities - CSL
05 Dec 15:55	Share

Initial Director's Interest Notice
05 Dec 15:44	Share

Application for quotation of securities - CSL
03 Dec 13:28	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $241.60		Change 0.680(0.28%)		Mkt cap ! $116.9B

Open	High	Low	Value	Volume
$240.50	$242.88	$240.10	$114.7M	474.9K

Buyers (Bids)

No.	Vol.	Price($)
2	539	$241.60

Sellers (Offers)

Price($)	Vol.	No.
$241.64	118	2

View Market Depth

No.	Vol.	Price($)
1	30	241.600
1	40	241.170
1	60	241.130
9	464	241.000
2	187	240.990

Price($)	Vol.	No.
241.640	118	2
242.090	3	1
242.440	913	2
242.490	752	1
242.500	607	1

Last trade - 16.10pm 14/07/2025 (20 minute delay)

CSL (ASX) Chart

CSL LIMITED

Latest Threads

Want to reach millions of investors? Get in touch

Timeline

Featured News

Latest Articles

Biotech stocks that survived April 2 feel the heat of Trump's new pharma threat

If you thought a 104% tariff on China was bad enough, Trump’s found another way to make the markets about himself @ now confirming major tariffs on pharmaceuticals.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout th...

CSL survives a brutal sell-off but dips on US tariff response as investors eye pharma risk

CSL Ltd (ASX:CSL) has seen shares fall nearly half a percent in afternoon trades on Thursday as the company responds to Trump's US tariffs.

CSL up 6% on strong demand for CSL Behring business

CSL Ltd has reported rises in profit and revenue for the first half of the 2025 fiscal year, with particular growth in its CSL Behring arm

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News